Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration. (2021)
https://pubmed.ncbi.nlm.nih.gov/34083206/

Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? (2021)
https://pubmed.ncbi.nlm.nih.gov/34130984/

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33367900/

Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/31749988/

Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice (2019)
https://pubmed.ncbi.nlm.nih.gov/31138285/